🇺🇸 FDA

Drug profile · INN

dexmedetomidine hydrochloride

DEXMEDETOMIDINE HYDROCHLORIDE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: buccal, sublingual. Current US regulatory status: approved.

Key facts

INN dexmedetomidine hydrochloride
Brand DEXMEDETOMIDINE HYDROCHLORIDE
Route BUCCAL, SUBLINGUAL
Formulation INJECTABLE
Originator Regeneron Ireland Designated Activity Company (DAC)

Frequently asked questions

What is dexmedetomidine hydrochloride?

dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: buccal, sublingual. Current US regulatory status: approved.

What is the brand name for dexmedetomidine hydrochloride?

DEXMEDETOMIDINE HYDROCHLORIDE is a marketed brand name for dexmedetomidine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dexmedetomidine hydrochloride?

dexmedetomidine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.